|
1
|
López-Gómez M, Malmierca E, de Górgolas M
and Casado E: Cancer in developing countries: The next most
preventable pandemic. The global problem of cancer. Crit Rev Oncol
Hematol. 88:117–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sankaranarayanan R, Ramadas K and Qiao YL:
Managing the changing burden of cancer in Asia. BMC Med. 12:32014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Katzka DA: Recent advances in non-invasive
esophageal tissue sampling. Curr Gastroenterol Rep. 19:92017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peery AF, Crockett SD, Barritt AS, Dellon
ES, Eluri S, Gangarosa LM, Jensen ET, Lund JL, Pasricha S, Runge T,
et al: Burden of gastrointestinal, liver, and pancreatic diseases
in the United States. Gastroenterology. 149:1731–1741.e3. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu ZJ, Hu Y, Zhao YF, Chen XZ, Chen LQ
and Chen YT: Early recurrence and death after esophagectomy in
patients with esophageal squamous cell carcinoma. Ann Thorac Surg.
91:1502–1508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: biomarkers, functions and therapy. Trends in
Mol Med. 20:460–469. 2014. View Article : Google Scholar
|
|
9
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li C, Lei B, Huang S, Zheng M, Liu Z, Li Z
and Deng Y: H19 derived microRNA-675 regulates cell proliferation
and migration through CDK6 in glioma. Am J Transl Res. 7:1747–1764.
2015.PubMed/NCBI
|
|
11
|
Keniry A, Oxley D, Monnier P, Kyba M,
Dandolo L, Smits G and Reik W: The H19 lincRNA is a developmental
reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell
Biol. 14:659–665. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng
R, Wang Y, Huang J, Xu M, Yan J and Yu J: lncRNA H19/miR-675 axis
represses prostate cancer metastasis by targeting TGFBI. FEBS J.
281:3766–3775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung
JJ and Kwok TT: Oncofetal H19-derived miR-675 regulates tumor
suppressor RB in human colorectal cancer. Carcinogenesis.
31:350–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang Z, Zhang H, Liu C, Yin J, Tong S, Lv
J, Wei S and Wu S: β3GnT8 promotes colorectal cancer cells invasion
via CD147/MMP2/Galectin3 axis. Front Physiol. 9:5882018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang DY, Sp N, Kim DH, Joung YH, Lee HG,
Park YM and Yang YM: Salidroside inhibits migration, invasion and
angiogenesis of MDA-MB 231 TNBC cells by regulating EGFR/Jak2/STAT3
signaling via MMP2. Int J Oncol. 53:877–885. 2018.PubMed/NCBI
|
|
17
|
Marshall DC, Lyman SK, McCauley S,
Kovalenko M, Spangler R, Liu C, Lee M, O'Sullivan C, Barry-Hamilton
V, Ghermazien H, et al: Selective allosteric inhibition of MMP9 is
efficacious in preclinical models of ulcerative colitis and
colorectal cancer. PLoS One. 10:e01270632015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grauzam S, Brock AM, Holmes CO, Tiedeken
JA, Boniface SG, Pierson BN, Patterson DG, Coaxum SD, Neskey DM and
Rosenzweig SA: NEDD9 stimulated MMP9 secretion is required for
invadopodia formation in oral squamous cell carcinoma. Oncotarget.
9:25503–25516. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuan YL, Wang YM, Liu H, Qin GF, Tang AG
and Duan Y: Aberrant expression of E-cadherin in lung tissues of
patients with probable lung cancer. Asian Pac J Cancer Prev.
13:5149–5153. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wong TS, Gao W and Chan JY: Interactions
between E-cadherin and microRNA deregulation in head and neck
cancers: the potential interplay. Biomed Res Int. 2014:1260382014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Repetto O, De Paoli P, De Re V, Canzonieri
V and Cannizzaro R: Levels of soluble E-cadherin in breast,
gastric, and colorectal cancers. Biomed Res Int. 2014:4080472014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Techasen A, Loilome W, Namwat N, Khuntikeo
N, Puapairoj A, Jearanaikoon P, Saya H and Yongvanit P: Loss of
E-cadherin promotes migration and invasion of cholangiocarcinoma
cells and serves as a potential marker of metastasis. Tumour Biol.
35:8645–8652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang CA, Drasin D, Pham C, Jedlicka P,
Zaberezhnyy V, Guney M, Li H, Nemenoff R, Costello JC, Tan AC and
Ford HL: Homeoprotein Six2 promotes breast cancer metastasis via
transcriptional and epigenetic control of E-cadherin expression.
Cancer Res. 74:7357–7370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kreiseder B, Orel L, Bujnow C, Buschek S,
Pflueger M, Schuett W, Hundsberger H, de Martin R and Wiesner C:
α-Catulin downregulates E-cadherin and promotes melanoma
progression and invasion. Int J Cancer. 132:521–530. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shin VY and Chu KM: MiRNA as potential
biomarkers and therapeutic targets for gastric cancer. World J
Gastroenterol. 20:10432–10439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoshizawa JM and Wong DT: Salivary
microRNAs and oral cancer detection. Methods Mol Biol. 936:313–324.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rocci A, Hofmeister CC and Pichiorri F:
The potential of miRNAs as biomarkers for multiple myeloma. Expert
Rev Mol Diagn. 14:947–959. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan Y, Liang H, Chen W, Zhang H, Wang N,
Wang F, Zhang S, Liu Y, Zhao C, Yan X, et al: microRNA-200b and
microRNA-200c promote colorectal cancer cell proliferation via
targeting the reversion-inducing cysteine-rich protein with Kazal
motifs. RNA Biol. 12:276–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yamada N, Tsujimura N, Kumazaki M,
Shinohara H, Taniguchi K, Nakagawa Y, Naoe T and Akao Y: Colorectal
cancer cell-derived microvesicles containing microRNA-1246 promote
angiogenesis by activating Smad 1/5/8 signaling elicited by PML
down-regulation in endothelial cells. Biochim Biophys Acta.
1839:1256–1272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jin M, Zhang T, Liu C, Badeaux MA, Liu B,
Liu R, Jeter C, Chen X, Vlassov AV and Tang DG: miRNA-128
suppresses prostate cancer by inhibiting BMI-1 to inhibit
tumor-initiating cells. Cancer Res. 74:4183–4195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiao R, Li C and Chai B: miRNA-144
suppresses proliferation and migration of colorectal cancer cells
through GSPT1. Biomed Pharmacother. 74:138–144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu HT, Xing AY, Chen X, Ma RR, Wang YW,
Shi DB, Zhang H, Li P, Chen HF, Li YH and Gao P: MicroRNA-27b,
microRNA-101 and microRNA-128 inhibit angiogenesis by
down-regulating vascular endothelial growth factor C expression in
gastric cancers. Oncotarget. 6:37458–37470. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tao J, Zhi X, Zhang X, Fu M, Huang H, Fan
Y, Guan W and Zou C: miR-27b-3p suppresses cell proliferation
through targeting receptor tyrosine kinase like orphan receptor 1
in gastric cancer. J Exp Clin Cancer Res. 34:1392015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He D, Wang J, Zhang C, Shan B, Deng X, Li
B, Zhou Y, Chen W, Hong J, Gao Y, et al: Down-regulation of
miR-675-5p contributes to tumor progression and development by
targeting pro-tumorigenic GPR55 in non-small cell lung cancer. Mol
Cancer. 14:732015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou YW, Zhang H, Duan CJ, Gao Y, Cheng
YD, He D, Li R and Zhang CF: miR-675-5p enhances tumorigenesis and
metastasis of esophageal squamous cell carcinoma by targeting
REPS2. Oncotarget. 7:30730–30747. 2016.PubMed/NCBI
|
|
36
|
Wang X, Yang B, She Y and Ye Y: The lncRNA
TP73-AS1 promotes ovarian cancer cell proliferation and metastasis
via modulation of MMP2 and MMP9. J Cell Biochem. Jun 15–2018.(Epub
ahead of print).
|
|
37
|
Li H, Zhang Y, Hai J, Wang J, Zhao B, Du L
and Geng X: Knockdown of TRIM31 suppresses proliferation and
invasion of gallbladder cancer cells by down-regulating MMP2/9
through the PI3K/Akt signaling pathway. Biomed Pharmacother.
103:1272–1278. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kalhori V and Törnquist K: MMP2 and MMP9
participate in S1P-induced invasion of follicular ML-1 thyroid
cancer cells. Mol Cell Endocrinol. 404:113–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jacob A, Jing J, Lee J, Schedin P, Gilbert
SM, Peden AA, Junutula JR and Prekeris R: Rab40b regulates
trafficking of MMP2 and MMP9 during invadopodia formation and
invasion of breast cancer cells. J Cell Sci. 126:4647–4658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu J, Ping W, Zu Y and Sun W:
Correlations of lysyl oxidase with MMP2/MMP9 expression and its
prognostic value in non-small cell lung cancer. Int J Clin Exp
Pathol. 7:6040–6047. 2014.PubMed/NCBI
|
|
41
|
Qiu X, Cheng JC, Chang HM and Leung PC:
COX2 and PGE2 mediate EGF-induced E-cadherin-independent human
ovarian cancer cell invasion. Endocr Relat Cancer. 21:533–543.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cai D, Chen SC, Prasad M, He L, Wang X,
Choesmel-Cadamuro V, Sawyer JK, Danuser G and Montell DJ:
Mechanical feedback through E-cadherin promotes direction sensing
during collective cell migration. Cell. 157:1146–1159. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen D, Wu Z, Luo LJ, Huang X, Qian WQ,
Wang H, Li SH and Liu J: E-cadherin maintains the activity of
neural stem cells and inhibits the migration. Int J Clin Exp
Pathol. 8:14247–14251. 2015.PubMed/NCBI
|
|
44
|
Brett A, Pandey S and Fraizer G: The
Wilms' tumor gene (WT1) regulates E-cadherin expression and
migration of prostate cancer cells. Mol Cancer. 12:32013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Canel M, Serrels A, Frame MC and Brunton
VG: E-cadherin-integrin crosstalk in cancer invasion and
metastasis. J Cell Sci. 126:393–401. 2013. View Article : Google Scholar : PubMed/NCBI
|
